Understanding Peptide Purity Standards

Purity is the single most cited specification in research peptide procurement, yet the number on a Certificate of Analysis (COA) often hides more than it reveals. This note unpacks how purity is measured, what the figure represents, and which adjacent specs deserve attention.

How HPLC purity is calculated

Reverse-phase high-performance liquid chromatography (RP-HPLC) separates the target peptide from related substances — truncated sequences, oxidation byproducts, deletion peptides, and residual scavengers. The purity figure is the area-under-curve of the main peak divided by the total integrated area, typically at 214 nm.

Why ≥98% is the working baseline

For most preclinical research applications, ≥98% purity by HPLC is treated as the standard. Below that, impurities can confound assay readouts; above it, marginal gains in purity often come at disproportionate cost.

• ≥95%: acceptable for screening and qualitative work
• ≥98%: standard for quantitative in vitro studies
• ≥99%: required for sensitive structural or pharmacokinetic work

Specs that matter beyond purity

A clean HPLC trace alone does not guarantee a usable lot. Always cross-reference mass spectrometry confirmation, water content (Karl Fischer), acetate or TFA counter-ion content, and bacterial endotoxin levels where applicable.

Purity is a necessary condition, not a sufficient one. Treat the COA as a profile, not a score.